Global digestive health products market size is estimated to be valued at USD 65.22 Bn in 2025 and is projected to reach USD 116.2 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 8.6% during the forecast period 2025-2032.
The digestive health products market is expanding rapidly due to growing awareness of gut health and overall well-being. Rising cases of IBS, IBD, and colorectal cancer, along with poor diets and stress, are driving consumers toward probiotics, supplements, and functional foods. This surge in the digestive health products market demand is further supported by innovations in strain-specific probiotics and fortified foods. As more people seek natural, preventive solutions, the market continues to grow across both healthcare and food sectors.
|
Current Event |
Description and its Impact |
|
Regulatory Policy Changes in Key Markets |
|
|
Microbiome Investment and Innovation |
|
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
Between September 2023 and August 2024 (TTM), the global export of Digestive Enzyme Supplements totaled 301 shipments. These exports were carried out by 45 exporters to 69 buyers, reflecting a decline of 9% compared to the previous twelve months.
In August 2024 alone, there were 39 shipments of Digestive Enzyme Supplements exported worldwide. This represents a 30% increase year-on-year from August 2023, as well as a 5% increase compared to July 2024.
In terms of product type, the probiotics segment is expected to dominate with a 30.0% share of the global digestive health products market in 2025, due to their proven role in maintaining and restoring gut microbiota balance. They help manage a range of gastrointestinal conditions such as irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), diarrhea, and constipation by promoting beneficial bacteria in the gut. Increasing awareness among consumers about the link between gut health and overall well-being, especially immunity and mental health, has further driven demand. Moreover, the availability of probiotics in various forms like yogurts, supplements, and functional foods makes them accessible and popular across age groups. The demand is also supported by clinical studies showing their efficacy in reducing antibiotic-associated side effects and enhancing digestion.
In December 2024, Swedish biotech firm BioGaia launched Gastrus PURE ACTION, a double‑strength, clean‑ingredient probiotic tailored to adults with sensitive digestive systems. The vegan, gluten‑ and lactose‑free capsules contain patented strains L. reuteri DSM 17938 and ATCC PTA 6475. Such developments are proliferating the digestive health market revenue.
In terms of indication, the gastroesophageal reflux disease (GERD) segment account for the largest share of the market in 2025, due to its high global prevalence, lifestyle-related risk factors, and rising awareness. Increasing consumption of processed foods, obesity, sedentary habits, and stress are key contributors to GERD, especially in urban populations. As a chronic condition, GERD often requires long-term treatment and lifestyle management, which sustains ongoing demand for antacids, proton pump inhibitors, dietary supplements, and diagnostic tools like endoscopy. Additionally, rising awareness about the complications of untreated GERD, such as esophagitis and Barrett’s esophagus, encourages early diagnosis and regular monitoring, further fueling market growth.
A new awareness campaign, “Relief Starts with Awareness,” launched during GERD Awareness Week by the International Foundation for Gastrointestinal Disorders (IFFGD), aims to educate the public on recognizing and managing gastroesophageal reflux disease (GERD). With 18–28 % of Americans affected, persistent heartburn or acid reflux is not normal and can lead to complications like Barrett’s esophagus.
In terms of age group, the adult segment dominates the global digestive health products market with the highest share in 2025, primarily due to the rising awareness of the connection between gut health and overall well-being. Factors such as poor diets, stress, sedentary lifestyles, and frequent use of antibiotics disrupt gut microbiota, leading to issues like bloating, constipation, acid reflux, and irritable bowel syndrome. Additionally, growing digestive health products market research on the gut-brain axis and immunity has encouraged adults to seek probiotics, fiber-rich foods, and digestive supplements. With aging, enzyme production and gastrointestinal motility decline, further driving demand for products that support digestion and nutrient absorption. This shift toward preventive care and functional foods is fueling adult interest in digestive health.
In October 2024, Zydus Wellness expanded its Complan brand into adult nutrition with the launch of Complan VieMax. Formulated with protein, prebiotics, and 2.6 billion probiotics per serving, the drink supports muscle health and gut wellness. Available in Vanilla and Chocolate flavors, VieMax is sold exclusively at pharmacies and contains 9% prebiotics to aid digestion and gut health.
In terms of distribution channel, the supermarkets and hypermarkets segment is expected to hold the greatest share of the market, driven by convenience shopping and several consumer and retail-driven trends. With rising awareness around gut health and immunity, more consumers are seeking probiotic-rich foods, fiber supplements, and functional beverages. Supermarkets respond to this demand by expanding their digestive health product offerings in visible, convenient sections. These large-format stores allow consumers to access food, supplements, and over-the-counter digestive aids in one location, making them ideal retail channels for busy households looking for daily digestive support. Supermarkets and hypermarkets are now positioning themselves as wellness destinations. For instance, retail chains like Walmart and Tesco have increased shelf space for functional foods, including yogurt, kombucha, and fiber-enriched products, to meet consumer expectations for healthier lifestyles, further proliferating the digestive health market revenue.
In November 2024, Tesco, the UK supermarket giant, introduced “Gut Sense”, a new own-label gut health range in early 2025. The range will feature probiotic-rich products such as kefir drinks, cereal bars, nuts, and vitamin-infused beverages, all aimed at supporting digestive wellness.
In terms of end users, the hospital and clinics segment is estimated to hold the maximum share in 2025, due to the rising prevalence of gastrointestinal disorders such as irritable bowel syndrome (IBS), gastroesophageal reflux disease (GERD), and inflammatory bowel diseases like Crohn’s and ulcerative colitis. These conditions often require advanced diagnostic procedures such as endoscopy, colonoscopy, and imaging, all of which are primarily performed in clinical settings. Additionally, hospitals manage severe and chronic cases that need multidisciplinary care, including gastroenterologists, dietitians, and surgeons. The availability of comprehensive testing, emergency services, and access to prescription therapies further reinforces hospitals and clinics as the primary centers for managing digestive health issues.
To learn more about this report, Download Free Sample
North America is the largest market for digestive health products, accounting for 34% of the global market share in 2025. The region covers a large and affluent population with increasing awareness of the importance of digestive health. Poor dietary habits, high consumption of processed foods, sedentary lifestyles, and stress contribute significantly to gastrointestinal issues such as acid reflux, bloating, constipation, and irritable bowel syndrome (IBS). In addition, the region has a large aging population, more prone to digestive disorders and nutrient malabsorption.
Additionally, increased awareness about the gut microbiome’s role in immunity and mental health has boosted sales of functional foods and supplements across the U.S. and Canada. Moreover, a well-established healthcare infrastructure allows for widespread diagnostic testing and treatment access, making hospitals, clinics, and pharmacies key distribution points. For instance, Megalabs USA, a subsidiary of Megalabs Inc., has launched Glutapak R, a probiotic and glutamine supplement designed to support gut health and promote intestinal healing across the Americas.
The Europe region is expected to exhibit the fastest growth, with 20% of the global market share in 2025. The region covers a large and aging population, which is at an increased risk of developing digestive disorders. Older adults are also more likely to use medications that can disrupt gut health, such as NSAIDs and antibiotics, increasing their vulnerability to gastrointestinal side effects. Additionally, age-related diseases like Parkinson’s and diabetes often have digestive symptoms, requiring specialized care. In countries like Germany, France, and Italy, where over 20% of the population is over 65, healthcare systems are seeing a rise in hospital visits for digestive disorders, endoscopic procedures, and demand for probiotics and digestive enzyme supplements.
Governments and healthcare providers are responding by increasing funding for geriatric gastroenterology services and promoting nutrition-focused interventions that support gut health. This demographic trend is playing a central role in shaping the digestive health products market landscape across Europe, with tailored solutions and preventive care becoming essential for aging populations. The region has a strong regulatory environment and a well-established healthcare infrastructure, which is conducive to the growth of the digestive health products market.
The U.S. digestive health products market is characterized by high prevalence of digestive disorders, over 70 million Americans suffer from gastrointestinal conditions such as acid reflux, irritable bowel syndrome (IBS), constipation, and bloating. These issues are often linked to poor dietary habits, stress, sedentary lifestyles, and widespread use of medications like NSAIDs and antibiotics that can disrupt gut flora. American consumers are highly engaged with health trends. The market for probiotic yogurts, kombucha, digestive enzyme capsules, and fortified snacks has grown rapidly, especially via e-commerce and health retailers.
For instance, in March 2025, Nature Made, launched clinically studied innovations and new formulations within its Digestive portfolio to deliver a range of probiotic, prebiotic, and fiber supplements for daily gut health support and benefits based on specific wellness needs. These additions come at a time when over 70% of U.S. adults prioritize gut wellness, reflecting consumer demand for scientifically backed products. This is further proliferating the digestive health market demand.
Germany’s market for digestive health products is supported by the increasing health awareness, and a cultural emphasis on gut wellness and preventive care. With over 22% of its population aged 65 and above, age-related gastrointestinal issues such as constipation, acid reflux, and food intolerance are becoming more common. This has led to rising consumption of digestive aids, including probiotics, fiber supplements, and herbal remedies. Additionally, recent trends show increased interest in the gut-brain connection, with German consumers actively seeking products that improve digestion and overall well-being.
In April 2025, at Infarma 2025, Europe’s leading pharmacy trade event held in Pritzwalk, German pharmacists noted a surge in popularity for synbiotic gummies products that combine probiotics and prebiotics underscoring a consumer shift toward smart digestive health solutions.
| Report Coverage | Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 65.22 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 8.6% | 2032 Value Projection: | USD 116.2 Bn |
| Geographies covered: |
|
||
| Segments covered: |
|
||
| Companies covered: |
Nestlé SA, Danone SA, Procter & Gamble Co., The Kraft Heinz Company, Bayer AG, Yakult Honsha Co., Ltd., Chr. Hansen Holding A/S, Align Technology, Inc., Sanofi SA, Pfizer Inc., The Clorox Company, Reckitt Benckiser Group plc., DSM Nutritional Products Ltd., Church & Dwight Co., Inc., and The Nature's Bounty Co. |
||
| Growth Drivers: |
|
||
| Restraints & Challenges: |
|
||
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
The digestive health products market value is at a crucial inflection point, with its trajectory increasingly shaped by a convergence of consumer behavior shifts, scientific validation, and regulatory alignment. The most significant value in this market lies not in its breadth of products but in the growing demand for mechanistic efficacy consumers and healthcare professionals alike are no longer satisfied with generic formulations and umbrella claims.
One cannot overlook the rising sophistication of probiotics, which have moved beyond traditional Lactobacillus and Bifidobacterium strains. Advanced formulations such as Clostridium butyricum, known for its butyrate-producing capacity and modulation of gut-brain signaling, are gaining clinical relevance. In fact, multiple double-blind RCTs from Europe have demonstrated a 40–60% improvement in IBS-D (Irritable Bowel Syndrome with Diarrhea) symptoms using strain-specific probiotics, suggesting a decisive shift from general digestive aids to targeted microbiome interventions.
Moreover, the segment of digestive enzymes is witnessing renewed credibility, particularly in pancreatic enzyme replacement therapy (PERT) and gluten-degrading enzymes. For example, Aspergillus niger-derived enzymes have shown enzymatic activity levels 3–4 times higher than older porcine-based analogs, aligning with rising vegan formulations without sacrificing clinical utility.
Equally critical is the functional fiber category, which has been underestimated in the past. Ingredients such as PHGG (Partially Hydrolyzed Guar Gum) and inulin are now receiving formulation prioritization due to their prebiotic index, fermentation efficiency, and low FODMAP status. With over 65% of gastroenterologists in a 2024 US-based poll stating they now recommend prebiotic fibers in chronic constipation management, this category is poised for a deeper clinical integration.
From a regulatory standpoint, EFSA’s tightening of health claim approvals in Europe and the FDA’s increased scrutiny of structure-function claims are inadvertently filtering the market for high-integrity players. Brands investing in biomarker-backed trials, such as measuring zonulin levels for gut permeability or CRP for systemic inflammation, will hold a lasting competitive edge. In my view, this bifurcation will intensify over the next 2–3 years, marginalizing commoditized products in favor of evidence-driven portfolios.
*Definition: Global digestive health products market refers to the commercial sector encompassing products, services, and treatments focused on promoting and maintaining a healthy digestive system. It includes a wide range of products such as probiotics, prebiotics, digestive supplements, digestive enzymes, fiber-based products, and diagnostic tests for various digestive disorders. The market also includes healthcare services provided by healthcare professionals specializing in gastroenterology and related fields, as well as pharmaceuticals and therapeutic interventions targeted at digestive health conditions. The primary goal of the global digestive health products market is to support optimal digestive function, alleviate digestive disorders, and improve overall gastrointestinal well-being.
Share
Share
About Author
Sakshi Suryawanshi is a Research Consultant with 6 years of extensive experience in market research and consulting. She is proficient in market estimation, competitive analysis, and patent analysis. Sakshi excels in identifying market trends and evaluating competitive landscapes to provide actionable insights that drive strategic decision-making. Her expertise helps businesses navigate complex market dynamics and achieve their objectives effectively.
Missing comfort of reading report in your local language? Find your preferred language :
Transform your Strategy with Exclusive Trending Reports :
Frequently Asked Questions
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
Schedule a meeting with report Author
